Informations:
Erreur:
ID
24013
Description
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.; ODM derived from: https://clinicaltrials.gov/show/NCT00460941
Lien
https://clinicaltrials.gov/show/NCT00460941
Mots-clés
Versions (1)
- 22/07/2017 22/07/2017 -
Téléchargé le
22 juillet 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Diabetes Mellitus, Type 2 NCT00460941
Eligibility Diabetes Mellitus, Type 2 NCT00460941
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00460941
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Gender | Postmenopausal state | Female Sterilization | Age
Item
male,and post-menopausal or surgically sterilized female, patients, 18-75 years of age;
boolean
C0079399 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0015787 (UMLS CUI [3])
C0001779 (UMLS CUI [4])
C0232970 (UMLS CUI [2])
C0015787 (UMLS CUI [3])
C0001779 (UMLS CUI [4])
Diabetes Mellitus, Non-Insulin-Dependent | Metformin Stable
Item
type 2 diabetes mellitus, with stable metformin treatment for >=3 months;
boolean
C0011860 (UMLS CUI [1])
C0025598 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0025598 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Glycosylated hemoglobin A
Item
hba1c >=7.0% and <=9.5% at screening;
boolean
C0019018 (UMLS CUI [1])
Stable body weight
Item
stable weight +/-10% for >=3 months before screening.
boolean
C0517386 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus;
boolean
C0011854 (UMLS CUI [1])
Gastrointestinal Diseases
Item
clinically significant gastrointestinal disease;
boolean
C0017178 (UMLS CUI [1])
Hypoglycemic Agents | Metformin Excluded
Item
treatment with any anti-hyperglycemic medication other than metformin monotherapy during last 3 months;
boolean
C0020616 (UMLS CUI [1])
C0025598 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C0025598 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
Weight-Loss Agents
Item
use of weight-lowering medications in the last 3 months;
boolean
C0376606 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled hypertension;
boolean
C1868885 (UMLS CUI [1])
Exposure to Glucagon-Like Peptide 1 | Exposure to Glucagon-Like Peptide 1 Analogue
Item
previous exposure to glp-1 or glp-1 analogues.
boolean
C0332157 (UMLS CUI [1,1])
C0061355 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0061355 (UMLS CUI [2,2])
C0243071 (UMLS CUI [2,3])
C0061355 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0061355 (UMLS CUI [2,2])
C0243071 (UMLS CUI [2,3])